Literature DB >> 3074284

Systemic lupus erythematosus.

G R Hughes1.   

Abstract

Systemic lupus erythematosus is a common disease--studies throughout the world broadly agree on a prevalence of 1 in 1000 women. Recently an important clinical advance has come from the description of a syndrome of recurrent thrombosis, recurrent abortion and neurological disease associated with antiphospholipid antibodies. The discovery that immunological mechanisms may apply in some cases of thrombosis has led to new insights into the aetiology and treatment of vascular disease in general.

Entities:  

Mesh:

Year:  1988        PMID: 3074284      PMCID: PMC2428894          DOI: 10.1136/pgmj.64.753.517

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  10 in total

1.  The anticardiolipin syndrome.

Authors:  G R Hughes; N N Harris; A E Gharavi
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

2.  Cellular protein and RNA antigens in autoimmune disease.

Authors:  R M Bernstein; C C Bunn; G R Hughes; A M Francoeur; M B Mathews
Journal:  Mol Biol Med       Date:  1984-04

3.  Ozone depletion and cancer risk.

Authors:  R R Jones
Journal:  Lancet       Date:  1987-08-22       Impact factor: 79.321

Review 4.  The treatment of SLE: the case of conservative management.

Authors:  G R Hughes
Journal:  Clin Rheum Dis       Date:  1982-04

5.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

6.  Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.

Authors:  R A Asherson; D Mercey; G Phillips; N Sheehan; A E Gharavi; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103

7.  Mortality in systemic lupus erythematosus.

Authors:  E Ginzler; A Berg
Journal:  J Rheumatol Suppl       Date:  1987-06

8.  Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens.

Authors:  D A Bell; P J Maddison
Journal:  Arthritis Rheum       Date:  1980-11

9.  Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. Possible role of anti-idiotypic antibodies.

Authors:  B H Hahn; F M Ebling
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

10.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

Authors:  A H Fielder; M J Walport; J R Batchelor; R I Rynes; C M Black; I A Dodi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05
  10 in total
  2 in total

1.  Systemic lupus erythematosus in 50 year olds.

Authors:  I Domenech; O Aydintug; R Cervera; M Khamashta; A Jedryka-Goral; J L Vianna; G R Hughes
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

2.  C5a alters blood-brain barrier integrity in experimental lupus.

Authors:  Alexander Jacob; Bradley Hack; Eddie Chiang; Joe G N Garcia; Richard J Quigg; Jessy J Alexander
Journal:  FASEB J       Date:  2010-01-11       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.